Evidence map›Paper›PMID 25774684›Full record

ArticlePloS one2015

Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells.

Daniela Pezzolla, Javier López-Beas, Christian C Lachaud, Alejandro Domínguez-Rodríguez, Tarik Smani, Abdelkrim Hmadcha, Bernat Soria

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. A new shortened protocol to obtain islet-like cells from hESC-derived ductal cells.In vitro cellular & developmental biology. Animal · 2021
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Advances in Research on the Protective Mechanisms of Traditional Chinese Medicine (TCM) in IsletEvidence-based complementary and alternative medicine : eCAM · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Daniela PezzollaDepartment of Stem Cells, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER)-Fundación Progreso y Salud (FPS), Sevilla, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Barcelona, Spain.
Javier López-BeasDepartment of Stem Cells, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER)-Fundación Progreso y Salud (FPS), Sevilla, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Barcelona, Spain.
Christian C LachaudDepartment of Stem Cells, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER)-Fundación Progreso y Salud (FPS), Sevilla, Spain.
Alejandro Domínguez-RodríguezCardiovascular Pathophysiology, Institute of Biomedicine of Seville (IBIS), Sevilla, Spain.
Tarik SmaniCardiovascular Pathophysiology, Institute of Biomedicine of Seville (IBIS), Sevilla, Spain.
Abdelkrim HmadchaDepartment of Stem Cells, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER)-Fundación Progreso y Salud (FPS), Sevilla, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Barcelona, Spain.
Bernat SoriaDepartment of Stem Cells, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER)-Fundación Progreso y Salud (FPS), Sevilla, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Barcelona, Spain.
Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESFundación Progreso y Salud · ESInstituto de Biomedicina de Sevilla · ESCentro Andaluz de Biología Molecular y Medicina Regenerativa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human embryonic stem cells (hESCs) retain the extraordinary capacity to differentiate into different cell types of an adult organism, including pancreatic β-cells. For this particular lineage, although a lot of effort has been made in the last ten years to achieve an efficient and reproducible differentiation protocol, it was not until recently that this aim was roughly accomplished. Besides, several studies evidenced the impact of resveratrol (RSV) on insulin secretion, even though the mechanism by which this polyphenol potentiates glucose-stimulated insulin secretion (GSIS) is still not clear. The aim of this study was to optimize an efficient differentiation protocol that mimics in vivo pancreatic organogenesis and to investigate whether RSV may improve the final maturation step to obtain functional insulin-secreting cells. Our results indicate that treatment of hESCs (HS-181) with activin-A induced definitive endoderm differentiation as detected by the expression of SOX17 and FOXA2. Addition of retinoic acid (RA), Noggin and Cyclopamine promoted pancreatic differentiation as indicated by the expression of the early pancreatic progenitor markers ISL1, NGN3 and PDX1. Moreover, during maturation in suspension culture, differentiating cells assembled in islet-like clusters, which expressed specific endocrine markers such as PDX1, SST, GCG and INS. Similar results were confirmed with the human induced Pluripotent Stem Cell (hiPSC) line MSUH-001. Finally, differentiation protocols incorporating RSV treatment yielded numerous insulin-positive cells, induced significantly higher PDX1 expression and were able to transiently normalize glycaemia when transplanted in streptozotocin (STZ) induced diabetic mice thus promoting its survival. In conclusion, our strategy allows the efficient differentiation of hESCs into pancreatic endoderm capable of generating β-cell-like cells and demonstrates that RSV improves the maturation process.

Indexed as

AnimalsCell DifferentiationCell LineDiabetes Mellitus, ExperimentalEmbryonic Stem CellsHeterograftsHumansInsulin-Secreting CellsMiceMice, Inbred NODMice, SCIDResveratrolStilbenesResveratrolStilbenes

Identifiers

PMID25774684
PMCPMC4361612
OpenAlexW2087007752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.